ANL Prakiraan wutah bathi kanggo taun ngarep Adlai Nortye Ltd

Regulatory barrier risks between China and the US are weighing on quotes, as evidenced by the current consensus EPS growth forecast for next year in the GURU.Markets terminal, where the value -59.90 shows the current figure. The resilience of Adlai Nortye Ltd. (ANL) is based on the global distribution of clinics, while the operating model relies on outsourced production to minimize costs.
ANL (Adlai Nortye Ltd.): rincian analitis lan laporan miturut indikator

This indicator measures the weighted average analyst expectation for earnings per share growth over the next year, reflecting the market consensus on business development rates. The formula's dynamics react sharply to operational reports, transforming the trend of consensus EPS estimates into a leading indicator of value. For Adlai Nortye Ltd. (ANL), the growth of this metric confirms the effectiveness of scaling complex pharmaceutical delivery chains for oncology drugs.